Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Bullock, W. M. Articles by Perrone-Bizzozero, N. I. Search for Related Content PubMed Citation Articles by Bullock, W. M. Articles by Perrone-Bizzozero, N. I. Schizophrenia Spectrum Disorders Genetics Related Article

Altered Expression of Genes Involved in GABAergic Transmission and Neuromodulation of Granule Cell Activity in the Cerebellum of Schizophrenia Patients

OBJECTIVE: Deficits in gamma-aminobutyric acid (GABA) signaling have been described in the prefrontal cortex, limbic system, and cerebellum in individuals with schizophrenia. The purpose of the present study was to further investigate cerebellar gene expression alterations as they relate to decreases in GABAergic transmission by examining the expression of GABAergic markers, N-methyl-D-aspartic-acid (NMDA) receptor subunits, and cerebellum neuromodulators in individuals with schizophrenia. METHOD: Subjects were postmortem men with a diagnosis of schizophrenia (N=13) and a postmortem interval-matched non-psychiatric male comparison group (N=13). The authors utilized real-time-quantitative polymerase chain reaction (PCR) to measure mRNA levels of the following GABAergic markers: glutamic acid decarboxylase (GAD) 65 and 67; GABA plasma membrane transporter-1 (GAT-1); GABA type A (GABA_A) receptor subunits ₆, β₃, and ; and parvalbumin. In addition, real-time-quantitative PCR was utilized to assess mRNA levels of the NMDA receptor (NR) subunits NR1, NR2-A, NR2-B, NR2-C, and NR2-D as well as the cerebellar neuromodulators glutamate receptor (GluR)-6, kainate-preferring glutamate receptor subunit-2 (KA2), metabotropic glutamate receptor (mGluR)-2 and mGluR3, and neuronal nitric oxide synthase. Measurements for mRNA levels were determined using lateral cerebellar hemisphere tissue from both schizophrenia and comparison subjects. RESULTS: Schizophrenia subjects showed significant decreases in mRNA levels of GAD₆₇, GAD₆₅, GAT-1, mGluR2, and neuronal nitric oxide synthase. Increases in GABA_A-₆ and GABA_A- as well as GluR6 and KA2 were also observed. Medication effects on the expression of the same genes were examined in rats treated with either haloperidol (Sprague-Dawley rats [N=16]) or clozapine (Long-Evans rats [N=20]). Both haloperidol and clozapine increased the levels of GAD₆₇ in the cerebellum and altered the expression of other cerebellar mRNAs. CONCLUSIONS: These findings suggest that GABA transmission is decreased in the cerebellar cortices in individuals with schizophrenia and additional gene expression changes may reflect an attempt to increase GABA neurotransmission at the cerebellar glomerulus.

Related Article:

In this Issue
Am J Psychiatry 2008 165: A24. [Full Text] [PDF]

This article has been cited by other articles:

				S. H. Fatemi and T. D. Folsom The Neurodevelopmental Hypothesis of Schizophrenia, Revisited Schizophr Bull, May 1, 2009; 35(3): 528 - 548. [Abstract] [Full Text] [PDF]

				J. PEEDICAYIL The Role of Epigenetics in Altered Gene Expression Involved in GABAergic Transmission in the Cerebellum of Schizophrenia Patients Am J Psychiatry, April 1, 2009; 166(4): 493 - 493. [Full Text] [PDF]

				N. PERRONE-BIZZOZERO and W. M. BULLOCK Dr. Perrone-Bizzozero and W. Michael Bullock Reply Am J Psychiatry, April 1, 2009; 166(4): 493 - 494. [Full Text] [PDF]

				S. Akbarian Restoring GABAergic Signaling and Neuronal Synchrony in Schizophrenia Am J Psychiatry, December 1, 2008; 165(12): 1507 - 1509. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us